surely this is positive news. front line therapy for AML patients that are not eligible for chemo or stem cell therapy. I really liked the lead investigators presentation on why he initiated this study...watched this video a number of times!
https://us02web.zoom.us/rec/play/hgnowgzV_4EgPDOyraezpUlGSdG62sEqLDeiTgnQTgBYwvso2X3lJpuZP-ovk6TMUoKupoVcVhR0O1pa.hV_3-4JjjVhU3HUr?accessLevel=meeting&hasValidToken=false&canPlayFromShare=true&from=share_recording_detail&continueMode=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fus02web.zoom.us%2Frec%2Fshare%2Fp2Ok1KXI0VvrSeMPC3_jCwJionNWfVr8FWrh-tw_7qr_M6jcnkXQBhOp8i0p61S3.CNlw3hWXUlYcfbbc
good news is that the study is funded by MD Anderson and its a frontline therapy! We just had to spend a few hundred thousand to manufacture the CORE NK doses.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.37M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $9.689K | 2.768M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 75 | 71790139 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 86946524 | 26 |
View Market Depth
| Last trade - 12.54pm 01/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |